Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00627913 · ClinicalTrials.gov registry record · NA
Retrobulbar Injection of Anesthesia Versus Healon 5 in the Management of Intraoperative Floppy Iris Syndrome
A NA study, sponsored by Penn State University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT00627913 is a NA study that was terminated before completion, run by Penn State University. The registered enrollment target is 6 participants.
The verdict
NCT00627913, a NA study, was terminated before completion, sponsored by Penn State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
In this study, the investigators plan to compare the incidence and complications of intraoperative floppy iris syndrome (IFIS) during cataract surgery in patients taking tamsulosin (Flomax) and treated with retrobulbar injection of anesthesia, versus injection of Healon 5 viscoelastic into the anterior chamber.
Interventions
- PROCEDURE Healon 5 injection
- PROCEDURE Retrobulbar anesthetic injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-11-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00627913
The ClinicalTrials.gov registry entry for NCT00627913 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Healon 5 injection is the first listed.
NCT00627913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00627913 about?
NCT00627913 is a clinical study titled "Retrobulbar Injection of Anesthesia Versus Healon 5 in the Management of Intraoperative Floppy Iris Syndrome". In this study, the investigators plan to compare the incidence and complications of intraoperative floppy iris syndrome (IFIS) during cataract surgery in patients taking tamsulosin (Flomax) and treated with retrobulbar injection of anesthesia, versus injection of Healon 5 viscoelastic into the anter...
What is the current status of trial NCT00627913?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2008-02. Estimated completion is 2010-11-11.
What interventions are being tested in trial NCT00627913?
The interventions under investigation include: Healon 5 injection (PROCEDURE), Retrobulbar anesthetic injection (PROCEDURE).
Who is sponsoring clinical trial NCT00627913?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.